Manuel Beltrán-Visiedo

11PUBLICATIONS
42CO-AUTHORS
Gene and molecular therapyMolecular targetsHaematological tumoursPredictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 25, 2025
NK92 cells stably transfected with CD16 are efficient against multiple myeloma cells ex vivo and in vivo, especially if combined with daratumumab.

David Giraldos, Evelyn Galano-Frutos, Laura Cambronero-Arregui

|Jul 23, 2025
Author Correction: IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2- breast cancer via CX3CR1+ macrophages.

Giulia Petroni, Claudia Galassi, Kenneth H Gouin

|Jul 07, 2025
IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2- breast cancer via CX3CR1+ macrophages.

Giulia Petroni, Claudia Galassi, Kenneth H Gouin

|Jul 02, 2025
Regulation of inflammatory processes by caspases.

Manuel Beltrán-Visiedo, Ruth Soler-Agesta, Kristopher A Sarosiek

|Jun 10, 2025
CYPD limits HR+ mammary carcinogenesis in mice.

Aitziber Buqué, Manuel Beltrán-Visiedo, Ai Sato

|May 19, 2025
Partial mitochondrial involvement in the antiproliferative and immunostimulatory effects of PT-112.

Ruth Soler-Agesta, Manuel Beltrán-Visiedo, Ai Sato

Pageof 2

Frequent Collaborators

6 joint publications

Lorenzo Galluzzi

3 joint publications

Alberto Anel

3 joint publications

Ai Sato

3 joint publications

Xi Kathy Zhou